Oral nicotine marketing claims in direct-mail advertising
- PMID: 33958422
- PMCID: PMC9411885
- DOI: 10.1136/tobaccocontrol-2020-056446
Oral nicotine marketing claims in direct-mail advertising
Abstract
Background: Little is known regarding how oral nicotine products (eg, nicotine pouches, lozenges) are marketed to consumers, including whether potential implicit reduced harm claims are used. In the current study, we explored the marketing claims present in a sample of direct-mail oral nicotine advertisements sent to US consumers (March 2018-August 2020).
Methods: Direct-mail ads (n=50) were acquired from Mintel and dual-coded for the following claims: alternative to other tobacco products, ability to use anywhere, spit-free, smoke-free and product does not contain tobacco leaf. We merged the coded data with Mintel's volume estimate (number of mail pieces sent to consumers) and calculated the proportion of oral nicotine advertisements containing claims by category.
Results: Of the 38 million pieces of oral nicotine direct-mail sent to US consumers, most featured claims that the product could be used anywhere (84%, 31.8 million pieces); was an alternative to other tobacco products (69%, 26.1 million pieces); and did not contain tobacco leaf (eg, 'tobacco leaf-free', 'simple' approach of extracting nicotine from tobacco; 55%, 20.7 million pieces). A slightly smaller proportion contained claims that oral nicotine was 'spit-free' (52%, 19.8 million pieces) or 'smoke-free' (31%, 11.7 million pieces).
Conclusion: Our results provide an early indication of marketing claims used to promote oral nicotine. The strategies documented, particularly the use of language to highlight oral nicotine is tobacco-free, may covey these products as lower-risk to consumers despite the lack of evidence or proper federal authorisation that oral nicotine products are a modified-risk tobacco product. Future research is needed to examine consumer perceptions of such claims.
Keywords: non-cigarette tobacco products; public policy; surveillance and monitoring.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Going Smokeless: Promotional Features and Reach of US Smokeless Tobacco Direct-Mail Advertising (July 2017-August 2018).Nicotine Tob Res. 2021 Aug 4;23(8):1349-1357. doi: 10.1093/ntr/ntaa255. Nicotine Tob Res. 2021. PMID: 33270109
-
Tobacco-Derived Nicotine Pouch Brands and Marketing Messages on Internet and Traditional Media: Content Analysis.JMIR Form Res. 2023 Feb 15;7:e39146. doi: 10.2196/39146. JMIR Form Res. 2023. PMID: 36790840 Free PMC article.
-
A Content Analysis of Promotional Features in US Direct-Mail From Advertisements Across Tobacco Products From 2018 to 2020.Nicotine Tob Res. 2022 Oct 17;24(10):1627-1634. doi: 10.1093/ntr/ntac095. Nicotine Tob Res. 2022. PMID: 35417549 Free PMC article.
-
E-Cigarette Marketing and Communication: How E-Cigarette Companies Market E-Cigarettes and the Public Engages with E-cigarette Information.Nicotine Tob Res. 2019 Jan 1;21(1):14-24. doi: 10.1093/ntr/ntx284. Nicotine Tob Res. 2019. PMID: 29315420 Free PMC article. Review.
-
Moving targets: how the rapidly changing tobacco and nicotine landscape creates advertising and promotion policy challenges.Tob Control. 2022 Mar;31(2):222-228. doi: 10.1136/tobaccocontrol-2021-056552. Tob Control. 2022. PMID: 35241592 Free PMC article. Review.
Cited by
-
Evaluating the effects of nicotine concentration on the appeal and nicotine delivery of oral nicotine pouches among rural and Appalachian adults who smoke cigarettes: A randomized cross-over study.Addiction. 2024 Mar;119(3):464-475. doi: 10.1111/add.16355. Epub 2023 Nov 14. Addiction. 2024. PMID: 37964431 Free PMC article. Clinical Trial.
-
Classification, Perception, and Toxicity of Emerging Flavored Oral Nicotine Pouches.Int J Environ Res Public Health. 2023 Mar 3;20(5):4526. doi: 10.3390/ijerph20054526. Int J Environ Res Public Health. 2023. PMID: 36901533 Free PMC article. Review.
-
Perceptions of Oral Nicotine Pouches on Reddit: Observational Study.J Med Internet Res. 2022 Jul 15;24(7):e37071. doi: 10.2196/37071. J Med Internet Res. 2022. PMID: 35838764 Free PMC article.
-
Receiving coupons and discounts for nicotine pouches is associated with current use of nicotine pouches among United States adults: Results from the population assessment of tobacco and health (PATH) study wave 7 (2022-2023).Drug Alcohol Depend Rep. 2025 Aug 6;16:100370. doi: 10.1016/j.dadr.2025.100370. eCollection 2025 Sep. Drug Alcohol Depend Rep. 2025. PMID: 40823325 Free PMC article.
-
Content analysis of IQOS direct mail and email marketing in the US.Prev Med Rep. 2024 Jan 29;38:102634. doi: 10.1016/j.pmedr.2024.102634. eCollection 2024 Feb. Prev Med Rep. 2024. PMID: 38375169 Free PMC article.
References
-
- Food and Drug Administration . Smokeless tobacco products, including dip, snuff, Snus, and chewing tobacco, 2020. Available: https://www.fda.gov/tobacco-products/products-ingredients-components/smo...
-
- Food and Drug Administration . Dissolvable tobacco products, 2018. Available: https://www.fda.gov/tobacco-products/products-ingredients-components/dis...
-
- Kary T, Gretler C. Big tobacco hopes oral nicotine pouches fill the Vaping void. Bloomberg Businessweek, 2020. Available: https://www.bloomberg.com/news/articles/2020-07-17/big-tobacco-hopes-ora...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical